Skip to main content
SpringerLink
Log in

Gutartige Erkrankungen der Mamma

  • Chapter
Book cover Medikamentöse Therapie in der Gynäkologie

Part of the book series: Kliniktaschenbücher ((KTB))

Zusammenfassung

Entzündliche Veränderungen der Brust postpartal und während der Stillzeit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bässler R (1978) Pathologie der Brustdrüse. In: Doerr W, Seifert S, Uehlinger E (Hrsg) Spezielle pathologische Anatomie, Bd 11. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Bässler R, Kind M (1989) Pathologie, Systematik und Klassifizierung gutartiger Brusterkrankungen. Gynäkologe 22: 216–225

    PubMed  Google Scholar 

  • Bishop HM, Blamey RW (1979) A suggested classification of breast pain. Postgrad Med J 55 [Suppl 5]: 59–60

    PubMed  Google Scholar 

  • Blackmore WP (1977) Danazol in the treatment of benign breast disease. J Int Med Res [Suppl 3] 5: 101–108

    PubMed  Google Scholar 

  • Blichert-Toft M, Watt-Boolsen S (1984) Clinical approach to women with severe mastalgia and the therapeutic possibilities. Acta Obstet Gynecol Scand [Suppl] 123: 185–188

    Article  CAS  Google Scholar 

  • Bogaert L-J van (1986) Mastodynie et malidie fibrokystigue du sein. J Gynecol Obstet Biol Reprod (Paris) 15: 805–811

    Google Scholar 

  • Bohnet HG, Bertram M (1989) Die perioperativen Hormonspiegel bei prämenopausalen Patientinnen mit gutartigen Veränderungen und ihre .Beeinflußbarkeit durch verschiedene Hormontherapien. Gynäkologe 22: 255–261

    CAS  Google Scholar 

  • Brookshaw JD (1979) Danazol treatment of benign breast disease: a survey of USA multi-center-studies. Postgrad Med J [Suppl 5] 55: 52–58

    PubMed  Google Scholar 

  • Colin C, Gaspard U, Lambotte R (1978) Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol. Arch Gynecol 225: 7–15

    CAS  Google Scholar 

  • Dogliotti L, Mussa A, Sandrucci S (1983) Prolactin and benign breast disease with special emphasis to bromocriptin therapy. In: Angeli A, Bradlow HL, Dogliotti L (eds) Benign breast disease. Ravens, New York, pp 273–284

    Google Scholar 

  • Dogliotti L, Orlandi F, Forta M (1986) Bromocriptine treatment of fibrocystic breast disease. A survey. In: Dogliotti L, Mansel RE (eds) Fibrocystic breast disease. Cantor, Aulendorf, pp 46–53

    Google Scholar 

  • Döberl A, Tobiassen R, Rasmussen TH (1984) Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease. Acta Obstet Gynecol [Suppl] 123: 177–184

    Article  Google Scholar 

  • Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312: 146–151

    Article  PubMed  CAS  Google Scholar 

  • Fentinam IS, Calefi M, Brame K, Chandary MA, Hayword JL (1986) Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet I: 287–288

    Google Scholar 

  • Fournier D von, Kubli F, Bauer M, Weber E (1981) Hochdosierte Gestagen-Langzeittherapie beim Korpus-Karzinom, Einfluß auf Überlebenszeit. Geburtshilfe Frauenheilkd 41: 266–269

    Article  Google Scholar 

  • Fournier D von, Kubli F, Junkermann H, Bauer M, Legier U, Aribin B, Müller A (1984) Medikamentöse und operative Therapie der Mastopathie in Abhängigkeit vom Entartungsrisiko. Frauenarzt 4: 27–39

    Google Scholar 

  • Fournier D von, Junkermann H, Weber E (1987) Prospective studies of danazol, tamoxifen, progestogen and other hormones in benign breast diseases. Part II: Diagnosis and treatment. In: Wood C (ed) Benign breast disease: Is it worse treating? Royal Society Medicine, London (Medical Science Round table series No 6, pp 74–83)

    Google Scholar 

  • Friedrich M (1989) Mammographisches Bild gutartiger Brusterkrankungen. Gynäkologe 22: 230–237

    PubMed  CAS  Google Scholar 

  • Goebel R (1984) Results of a clinical evaluation of danazol in benign breast disease compared with local treatment, gestagens and bromocriptine. In: Baum M, George WD, Hughes LE (eds) Benign breast disease. Royal Society of Medicine, London (International Congress and Symposium Series No 76, pp 115–120)

    Google Scholar 

  • Goebel R, Junkermann H, Fournier D von (1989) Danazoltherapie bei gutartigen Brusterkrankungen. Gynäkologe 22: 262–270

    PubMed  CAS  Google Scholar 

  • Greenblatt RB, Dmowski WP, Mahesh VB, Scholer HFL (1971) Clinical studies with an antigonadotropin danazol. Fertil Steril 22: 102–112

    PubMed  CAS  Google Scholar 

  • Greenblatt RB, Nezhat C, Ben-Nun J (1980) The treatment of benign breast disease with danazol. Fertil Steril 34: 242–245

    PubMed  CAS  Google Scholar 

  • Gregl A (1986) Klinik und Therapie der Mastopathie. In: Gregl A, Bässler R, Sponer J (Hrsg) Pathomorphologie, Endokrinologie, Klinik und Therapie der Mastopathie. Informed, Gräfelfing (Medizin Aktuell: Brusterkrankungen, S 30–38)

    Google Scholar 

  • Hackelöer EJ, Dudar V, Lauth G (1989) Möglichkeiten der Ultraschalldiagnostik. Gynäkologe 22: 238–241

    PubMed  Google Scholar 

  • Hinton CP, Dowle C, Licker A, Roebuck EJ, Blamey RW (1988) Modification of the national history of cystic disease of the breasts by a short course of danazol: evidence from a controlled trial. Br J Clin Pract [Suppl 4] 56: 56–57

    Google Scholar 

  • Hughes LE, Mansel RE, Webster DJT (1989) Benign disorders and diseases of the breast. Baillière Tindall, London

    Google Scholar 

  • Humphrey LJ, Estes NC (1979) Aspects of fibrocystic disease of the breast. Treatment with danazol. Postgrad Med J [Suppl 5] 55: 48–52

    Google Scholar 

  • Junkermann H (1989) Diagnostik gutartiger Brusterkrankungen. Klinik. Gynäkologe 22: 216–225

    Google Scholar 

  • Kodlin D, Winger EE, Morgenstein NL, Chen V (1977) Chronic mastopathy and breast cancer. Cancer 39: 2603–2607

    Article  PubMed  CAS  Google Scholar 

  • Kumar S, Manod RE, Hughes LE, Edwards CA, Scanion MF (1985) Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release. Clin Endocrinol 23: 699–704

    Article  CAS  Google Scholar 

  • Lauersen NH, Wilson KH (1976) The effect of danazol in the treatment of chronic mastitis. Obstet Gynecol 48: 93–98

    PubMed  CAS  Google Scholar 

  • Maddox R, Harrison BJH, Mansel R (1988) Low dose danazol for mastalgia. Br J Clin Pract [Suppl] 42: 21

    Google Scholar 

  • Mansel RE, Wisbey JR, Hughes LE (1982) Controlled trial of the anti-gonadotropin danazol in painful nodular benign breast disease. Lancet I: 928–931

    Article  Google Scholar 

  • Navarro NS, Frauendorf RA (1988) Danazol for fibrocystic disease of the breast among Filipinos. Southeast Asian J Surg 11: 17–21

    Google Scholar 

  • Pahnke VG, Kitschke HJ, Bernauer M, Koll R (1985) Mastitis non-puerperalis –eine Erkrankung mit zunehmender Relevanz? Geburtshilfe Frauenheilkd 45: 25–35

    Google Scholar 

  • Peters F (1986) Prolaktin und Erkrankung der Brust. Urban & Schwarzenberg, München

    Google Scholar 

  • Peters F (1989) Die non-puerperale Mastitis. In: Künzel W, Kirschbaum M (Hrsg) Gießener Gynäkologische Fortbildung 1989. Springer, Berlin Heidelberg New York Tokyo, S 247–255

    Google Scholar 

  • Peters F, Breckwoldt M (1985) Serum-Prolaktinspiegel bei Patientinnen mit Mastopathie. Klinische Bedeutung. Verh Dtsch Ges Pathol 69: 401–404

    CAS  Google Scholar 

  • Peters F, Reck G, Zimmermann G, Breckwoldt M (1980) The effect of danazol on the ptuitary function, thyroid function and mastodynia. Arch Gynecol 230: 3–8

    Article  PubMed  CAS  Google Scholar 

  • Peters F, Pickart CR, Breckwoldt M (1983) Hormonal status of women with benign cystic breast disease: Clinical applications. In: Angeli A, Bradlow H, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 113–122

    Google Scholar 

  • Peters F, Geisthövel F, Schulze-Tollert J, Pfleiderer A, Breckwoldt M (1985) Die non-puerperale Mastitis –Ätiologie, Klinik und Therapie. Dtsch Med Wochenschr 110: 97–104

    Article  PubMed  CAS  Google Scholar 

  • Peters F, Geisthövel F, Breckwoldt M (1987) Treatment of benign breast diseases by dopamine agonists. In: Genazzani AR, Volpe A, Facchinetti F (Hrsg) Gynecological endocrinology. Parthenon, Lancaster, pp 275–283

    Google Scholar 

  • Pohl C, Decker K, Schindler AE (1985) Mastitis nonpuerperalis. Geburtshilfe Frauenheilkd 45: 302–307

    Article  PubMed  CAS  Google Scholar 

  • Preece PE, Hughes LE, Mansel RE, Baum M, Botton PM, Gravelle IH (1976) Clinical syndroms of mastalgia. Lancet II: 670–673

    Article  Google Scholar 

  • Schindler AE (1988) Danazol for the treatment of benign breast disease. In: Melis GB, Fournier D von (eds) Beyond symptomatic relief: danazol in recurring feminine disorders. Parthenon, Lancaster, pp 41–51

    Google Scholar 

  • Schindler AE (1989 a) Ätiologie und Epidemiologie gutartiger Brusterkrankungen. Gynäkologe 22: 212–215

    PubMed  CAS  Google Scholar 

  • Schindler AE (1989 b) Therapiemöglichkeiten der Mastodynie und Mastopathie. Spekulum 7: 20–24

    Google Scholar 

  • Schindler AE, Schindler E-M (1989) Wirkungsmechanismen von Danazol, eigene klinische Erfahrungen und Richtlinien für die Behandlung gutartiger Brusterkrankungen. Gynäkologe 22: 271–273

    PubMed  CAS  Google Scholar 

  • Scholefield AT, Duncan JL, Rogers K (1987) Review of a hospital experience of breast abscesses. Br J Surg 74: 461–470

    Article  Google Scholar 

  • Tolino A (1986) Benign breast disease and bromocriptin. G Ital Senolog 7: 17–22

    Google Scholar 

  • Umbach G, Mosny D, Bender HG (1989) Nonpuerperale Mastitis. Fortschr Med 107: 65–66

    PubMed  CAS  Google Scholar 

  • Vorherr H (1986) Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture and management. Am J Obstet Gynecol 154: 161–179

    PubMed  CAS  Google Scholar 

  • Wang DY, Fentinam IS (1985) Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 6: 5–36

    Article  PubMed  CAS  Google Scholar 

  • Wingrave SJ (1982) Progestogen effects and their relationship to lipoprotein changes. A report on the oral contraception study of the Royal College of General Practitioners. Acta Obstet Gynecol Scand [Suppl] 105: 33–36

    Article  CAS  Google Scholar 

  • Wisbey JR, Kumar S, Mansel RE, Preece PE, Pye JK, Hughes LE (1983) Natural history of breast pain. Lancet II: 672–674

    Article  Google Scholar 

Download references

Authors
  1. A. E. Schindler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Frauenklinik Mainz, In den alten Gärten 20, W-7770, Überlingen-Hödingen, Germany

    Volker Friedberg (em. Direktor) (em. Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schindler, A.E. (1991). Gutartige Erkrankungen der Mamma. In: Friedberg, V. (eds) Medikamentöse Therapie in der Gynäkologie. Kliniktaschenbücher. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95627-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-95627-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53220-0

  • Online ISBN: 978-3-642-95627-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation